News & Articles
Selected Filters:
A systems-level approach to understanding the immunology of COVID-19 in adults and children
Watch this on-demand webinar with Dr. Petter Brodin to learn about new insights into the immune response to SARS-CoV-2
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
What to look for in a life sciences partner
Susie Harborth explores what it takes to be a scientist entrepreneur and highlights the technology driving innovation in bioscience
AstraZeneca COVID-19 vaccine AZD1222 met primary efficacy endpoint
Two different dosing regimens demonstrated efficacy with one showing a better profile
The University of Oxford and Thermo Fisher Scientific ramp up COVID-19 testing capability
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Relief, NeuroRx enrolls 150 patients in phase 2b/3 trial of RLF-100 for critical COVID-19 with respiratory failure
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
Lonza announces broad selection of high-resolution HLA-typed primary cell lots to support biologic drug research
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
PerkinElmer SARS-CoV-2 RT-PCR Assay receives CE mark for saliva and sample pooling
Non-invasive sample collection and batch processing to test symptomatic and asymptomatic individuals
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
Zymo Research obtains CE IVD mark for its Quick SARS-CoV-2 Multiplex Kit
The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection
Beckman Coulter launches its Access SARS-CoV-2 IgM assay in countries accepting the CE mark
The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR
EUROIMMUN launches quantitative ELISA to measure SARS-CoV-2 antibodies against viral S1 protein
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development
More than 90% effective: Pfizer and BioNTech announce phase 3 COVID-19 vaccine results
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
New accessible microscope design opens up understanding of bio-molecules
The microscope aims to give microbiologists a greater insight into how single bio-molecules behave
Abbott introduces next-generation 3D cardiac mapping platform in Europe and Australia
The EnSite X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures






















